Literature DB >> 9989949

Signal transduction by fibroblast growth factor receptors.

P Klint1, L Claesson-Welsh.   

Abstract

The fibroblast growth factor family, with its prototype members acidic FGF (FGF-1) and basic FGF (FGF-2), binds to four related receptor tyrosine kinases, expressed on most types of cells in tissue culture. In many respects, the FGF receptors appear similar to other growth factor receptors. Thus, dimerization of receptor monomers upon ligand binding is likely to be a requisite for activation of the kinase domains, leading to receptor trans phosphorylation. FGF receptor-1 (FGFR-1), which shows the broadest expression pattern of the four FGF receptors contains at least seven tyrosine phosphorylation sites. A number of signal transduction molecules are affected by binding with different affinities to these phosphorylation sites. The potential roles of these signal transduction molecules in FGF-induced biological responses and in pathological processes are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989949     DOI: 10.2741/klint

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  84 in total

1.  Activated EGL-15 FGF receptor promotes protein degradation in muscles of Caenorhabditis elegans.

Authors:  Nathaniel J Szewczyk; Lewis A Jacobson
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 2.  A crucial role for fibroblast growth factor signaling in embryonic mammary gland development.

Authors:  Christian Dillon; Bradley Spencer-Dene; Clive Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 3.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

4.  Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.

Authors:  Anne M Moon; Deborah L Guris; Ji-heui Seo; Leiming Li; Jennetta Hammond; Amy Talbot; Akira Imamoto
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

5.  Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study.

Authors:  James Melrose; Susan Smith; Martin Cake; Richard Read; John Whitelock
Journal:  Histochem Cell Biol       Date:  2005-10-28       Impact factor: 4.304

6.  Impaired FGF signaling contributes to cleft lip and palate.

Authors:  Bridget M Riley; M Adela Mansilla; Jinghong Ma; Sandra Daack-Hirsch; Brion S Maher; Lisa M Raffensperger; Erilynn T Russo; Alexandre R Vieira; Catherine Dodé; Moosa Mohammadi; Mary L Marazita; Jeffrey C Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

7.  Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.

Authors:  Huixia Lu; Xinsheng Xu; Mei Zhang; Renhai Cao; Ebba Bråkenhielm; Changjiang Li; Huili Lin; Guihua Yao; Huiwen Sun; Lihang Qi; Mengxiong Tang; Hongyan Dai; Yanen Zhang; Runyi Su; Yanwen Bi; Yun Zhang; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

Review 8.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

9.  Inducible expression of FGF-3 in mouse mammary gland.

Authors:  Elly S W Ngan; Zhi-Qing Ma; Steven S Chua; Francesco J DeMayo; Sophia Y Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

10.  Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1.

Authors:  Antoni Wiedłocha; Trine Nilsen; Jørgen Wesche; Vigdis Sørensen; Jedrzej Małecki; Ewa Marcinkowska; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.